Aquatic Capital Management LLC Sells 43,865 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Aquatic Capital Management LLC trimmed its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 19.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 179,535 shares of the company's stock after selling 43,865 shares during the quarter. Aquatic Capital Management LLC owned approximately 0.08% of Bath & Body Works worth $6,961,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently made changes to their positions in the company. D1 Capital Partners L.P. bought a new stake in Bath & Body Works in the 4th quarter worth approximately $109,797,000. Norges Bank purchased a new stake in Bath & Body Works during the fourth quarter valued at $73,572,000. Arrowstreet Capital Limited Partnership lifted its holdings in Bath & Body Works by 79.1% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 3,882,047 shares of the company's stock valued at $150,507,000 after acquiring an additional 1,715,096 shares during the period. Alliancebernstein L.P. boosted its position in Bath & Body Works by 35.6% in the fourth quarter. Alliancebernstein L.P. now owns 5,178,447 shares of the company's stock worth $200,768,000 after purchasing an additional 1,360,264 shares during the last quarter. Finally, Anomaly Capital Management LP boosted its position in Bath & Body Works by 38.3% in the fourth quarter. Anomaly Capital Management LP now owns 4,860,876 shares of the company's stock worth $188,456,000 after purchasing an additional 1,346,752 shares during the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Price Performance

Shares of NYSE:BBWI traded up $1.10 during trading on Friday, hitting $31.15. The company had a trading volume of 1,228,123 shares, compared to its average volume of 4,784,089. The stock has a market cap of $6.64 billion, a price-to-earnings ratio of 7.60, a price-to-earnings-growth ratio of 0.92 and a beta of 1.69. The company has a fifty day simple moving average of $30.60 and a two-hundred day simple moving average of $33.81. Bath & Body Works, Inc. has a one year low of $24.96 and a one year high of $52.99.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The business had revenue of $2.79 billion for the quarter, compared to the consensus estimate of $2.78 billion. On average, equities research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 7th. Stockholders of record on Friday, February 21st were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.57%. The ex-dividend date was Friday, February 21st. Bath & Body Works's payout ratio is presently 21.98%.

Bath & Body Works declared that its Board of Directors has approved a share buyback program on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to repurchase up to 6.4% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's board believes its stock is undervalued.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on BBWI shares. Barclays lowered their price objective on shares of Bath & Body Works from $43.00 to $38.00 and set an "equal weight" rating on the stock in a research note on Monday, March 3rd. Wells Fargo & Company dropped their price target on shares of Bath & Body Works from $48.00 to $40.00 and set an "overweight" rating on the stock in a research note on Wednesday. Citigroup reduced their price objective on Bath & Body Works from $48.00 to $36.00 and set a "buy" rating for the company in a research note on Monday, April 7th. Telsey Advisory Group reissued an "outperform" rating and set a $43.00 price target on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Cowen reaffirmed a "buy" rating on shares of Bath & Body Works in a research note on Thursday, February 27th. Four analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $42.19.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.